DOACs

Advertisement
Patrick DalyAtrial Fibrillation | February 27, 2023
Researchers compared the safety and efficacy of two direct oral anticoagulants (DOACs), apixaban and rivaroxaban, ...
Read More
Patrick DalyAtrial Fibrillation | April 17, 2025
According to a study, published in Age and Ageing, the association between direct oral anticoagulant (DOAC) use and ...
Patrick DalyAtrial Fibrillation | April 17, 2025
Researchers performed a meta-analysis to assess the safety and efficacy of direct oral anticoagulants (DOAC) for ...
DocWire News EditorsAtrial Fibrillation | January 31, 2022
According to a study published in Cardiovascular Intervention and Therapeutics, the safety and efficacy profiles of left ...
DocWire News EditorsAtrial Fibrillation | April 17, 2025
Diabetes mellitus (DM) is a common comorbidity in patients with atrial fibrillation (AF) and is associated with an ...
Rob DillardCardiology | April 17, 2025
Lower Blood Pressure at Hospital Admission Increases the Risk of Heart Failure Death ...
Rebecca AraujoAtrial Fibrillation | April 17, 2025
A new study found that under-dosing of direct oral anticoagulants (DOACs) in patients with extreme obesity and atrial ...
Advertisement
Advertisement